Cell Lysis Market to Grow with a CAGR of 7.47% through 2030
Rising demand for biologics and personalized medicine is expected to
drive the Global Cell Lysis Market growth in the forecast period, 2026-2030.
According to
TechSci Research report, “Cell Lysis Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2030”, the Global Cell
Lysis Market stood at USD 3.16 billion in 2024 and is anticipated to grow with
a CAGR of 7.47% in the forecast period through 2030. The
increasing prevalence of chronic diseases such as cancer, cardiovascular
disorders, and neurodegenerative conditions has stimulated the demand for cell
lysis in diagnostics. Cell lysis plays a pivotal role in the isolation of
disease biomarkers from patient samples. This allows for the development of
more accurate diagnostic tests and the monitoring of disease progression. As
healthcare providers and researchers seek better ways to diagnose and treat
chronic diseases, the cell lysis market is poised to benefit significantly. The
application of cell lysis techniques in clinical diagnostics has expanded
beyond traditional research settings. Cell lysis is now a critical component of
various diagnostic assays, including polymerase chain reaction (PCR),
enzyme-linked immunosorbent assays (ELISA), and next-generation sequencing
(NGS). These techniques are used for detecting infectious diseases, genetic
disorders, and cancer biomarkers, among other clinical applications. The
growing demand for accurate and rapid diagnostic tests is a key driver for the
cell lysis market's growth.
The global cell lysis market owes much of its rapid growth to the
remarkable advancements within the biopharmaceutical industry. As
biopharmaceutical research continues to push the boundaries of therapeutic
development, cell lysis techniques will remain a cornerstone, enabling the
extraction of essential biomolecules, facilitating drug discovery, and
optimizing bioprocessing. Recent
advancements in genomics and proteomics research are focused on single-cell
analysis—a field that allows for the study of individual cells within a
heterogeneous population. Cell lysis plays a pivotal role in isolating and
analyzing the genetic and protein content of single cells, enabling researchers
to uncover cellular diversity, identify rare cell types, and gain insights into
cellular heterogeneity in health and disease. As the demands of genomics and
proteomics research evolve, so do the tools and reagents used in cell lysis.
Market players are continually developing innovative cell lysis solutions that
offer higher yields, improved selectivity, and increased automation. These
advancements cater to the specific needs of researchers working on cutting-edge
projects.
Genomics researchers rely on cell lysis to extract high-quality DNA from
cells and tissues. This extracted DNA serves as the raw material for a wide
range of applications, including whole-genome sequencing, polymerase chain
reaction (PCR), and genetic testing. Efficient cell lysis techniques are
essential to obtain intact and uncontaminated DNA, ensuring the accuracy of
genetic analyses. To study how genes are turned on or off in response to
various conditions or diseases, researchers use techniques like RNA sequencing
(RNA-Seq) and microarrays. Cell lysis plays a critical role in isolating RNA,
allowing scientists to measure gene expression levels accurately. This
information is invaluable in understanding disease mechanisms and identifying
potential therapeutic targets. Genomics research involves studying genetic
variations, such as single nucleotide polymorphisms (SNPs) and copy number
variations (CNVs), to elucidate their roles in health and disease. Cell lysis
is instrumental in extracting DNA for genetic variation analysis, contributing
to the identification of genetic markers associated with diseases and drug
responses.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Cell Lysis Market.”
The Global Cell Lysis Market is segmented into Type of Product , Type of cells, End user, Regional Distribution, and Company.
Based on Type of Product, Reagents segment is witnessing the fastest growth in the forecast period.This is attributed
to several factors including essential role in cell lysis process, diverse
range of reagents, and customization and flexibility. Also, Leading suppliers
in the Reagents segment invest heavily in research and development to ensure
high-quality, standardized products. These reagents undergo rigorous testing
and quality control processes, providing researchers with confidence in their
reliability and consistency. The
Reagents segment encompasses a wide variety of products, including detergents,
enzymes, buffers, and specialized chemicals. This diversity allows researchers
and professionals to choose reagents tailored to their specific cell lysis
requirements. The availability of such options ensures that researchers can
select the most suitable reagents for their applications. The Reagents segment
offers flexibility and customization, allowing users to adapt cell lysis
protocols to various sample types and research goals. Researchers can select
reagents that are optimized for different cell types, ensuring efficient cell
disruption while maintaining sample integrity.
Based on the region, The Asia Pacific region is experiencing the fastest growth in the Cell Lysis Market, driven by factors such as rising biotechnology and pharmaceutical research activities, increasing investments in life sciences, and a growing focus on precision medicine. Additionally, the expanding presence of biopharmaceutical companies and government support for research initiatives contribute to the market’s rapid expansion. The region's large patient population and increasing demand for personalized medicine further propel market growth.
Major companies operating in Global Cell Lysis Market are:
- Becton, Dickinson and Company
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Eppendorf AG
- Hoffmann-La Roche Ltd
- Labfreez Instruments Group Co. Ltd
- Merck KGaA
- Qsonica LLC
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“The biopharmaceutical industry's rapid expansion, with a focus on
biologics, monoclonal antibodies, and gene therapies, is a major driver. Cell
lysis is integral to the production of these advanced therapies, necessitating efficient
and high-yield cell disruption methods. The continuous progress in genomics and
proteomics research is increasing the need for cell lysis techniques. Ongoing
technological advancements in cell lysis are streamlining processes and improving
efficiency. Automated systems, microfluidic devices, and robotics are enhancing
precision, reducing human error, and expanding the capabilities of cell lysis
techniques. Moreover, the growing applications of cell lysis in clinical
diagnostics, molecular pathology, and personalized medicine are driving demand.
Cell lysis is essential for accurate genetic testing, biomarker identification,
and targeted therapy development. These technologies are expected to drive the
growth of the market.” said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“Cell Lysis Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, Segmented By Type of Product (Instruments
{Homogeniser, Centrifugation, Other Types of Products}, Reagents), By Type of cells
(Mammalian Cells, Microbial Cells, Plant Cells), By End user (Biotechnology or
Biopharmaceutical Companies, Research Laboratories and Academic Institutes,
Other End Users), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Cell Lysis Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Cell Lysis Market.
Contact
TechSci Research LLC
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com